Ricardo Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ricardo Costa has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Severo Torres
Department of Cardiology, Centro Hospitalar Universitário do Porto, Porto, Portugal
3 shared publications- André Dias-Frias
Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal
2 shared publications Carla Ferreira
Neurology Department, Hospital de Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal
2 shared publicationsJosé Nuno Alves
Neurology Department, Hospital de Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal
2 shared publications- João Pinho
Department of Neurology, University Hospital RWTH Aachen, Aachen, Germany
2 shared publications Manuel Ribeiro
Neuroradiology Department, Centro Hospitalar de Vila Nova de Gaia, R. Dr. Francisco Sá Carneiro, 4400-129, Vila Nova de Gaia, Portugal
2 shared publications
Latest Publications
- Open Access
- 9 December 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (12) , 444
Right Ventricular Septal Versus Apical Pacing: Long-Term Incidence of Heart Failure and Survival
The clinical benefits of right ventricular septal (RVS) pacing compared to those of right ventricular apical (RVA) pacing are still in debate. We aimed to compare the incidence of heart failure (HF) and all-cause mortality in patients submitted to RVS and RVA pacing during a longer follow-up. This a single-center, retrospective study analysis of consecutive patients submitted to pacemaker implantation. The primary outcome was defined as the occurrence of HF during follow-up. The secondary outcome was all-cause death. A total of 251 patients were included, 47 (18.7%) with RVS pacing. RVS pacing was associated to younger age, male gender, lower body mass index, ischemic heart disease, and atrial fibrillation. During a follow-up period of 5.2 years, the primary outcome occurred in 89 (37.1%) patients. RVS pacing was independently associated with a 3-fold lower risk of HF, after adjustment. The secondary outcome occurred in 83 (34.2%) patients, and pacemaker lead position was not a predictor. Fluoroscopy time and rate of complications (rarely life-threatening) were similar in both groups. Our study points to a potential clinical benefit of RVS positioning, with a 3.3-fold lower risk of HF, without accompanying increase in procedure complexity nor complication rate.
- 9 December 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (12) , 444
Open AccessRight Ventricular Septal Versus Apical Pacing: Long-Term Incidence of Heart Failure and Survival
The clinical benefits of right ventricular septal (RVS) pacing compared to those of right ventricular apical (RVA) pacing are still in debate. We aimed to compare the incidence of heart failure (HF) and all-cause mortality in patients submitted to RVS and RVA pacing during a longer follow-up. This a single-center, retrospective study analysis of consecutive patients submitted to pacemaker implantation. The primary outcome was defined as the occurrence of HF during follow-up. The secondary outcome was all-cause death. A total of 251 patients were included, 47 (18.7%) with RVS pacing. RVS pacing was associated to younger age, male gender, lower body mass index, ischemic heart disease, and atrial fibrillation. During a follow-up period of 5.2 years, the primary outcome occurred in 89 (37.1%) patients. RVS pacing was independently associated with a 3-fold lower risk of HF, after adjustment. The secondary outcome occurred in 83 (34.2%) patients, and pacemaker lead position was not a predictor. Fluoroscopy time and rate of complications (rarely life-threatening) were similar in both groups. Our study points to a potential clinical benefit of RVS positioning, with a 3.3-fold lower risk of HF, without accompanying increase in procedure complexity nor complication rate.
- Open Access
- 6 April 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (7) , 415-417
Successful Percutaneous Management of Iatrogenic Left Main Coronary Artery and Ascending Aorta Dissection
- 6 April 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (7) , 415-417
Open AccessSuccessful Percutaneous Management of Iatrogenic Left Main Coronary Artery and Ascending Aorta Dissection
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 164, 14-20
Heart Failure Incidence Following ST-Elevation Myocardial Infarction
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 164, 14-20
Heart Failure Incidence Following ST-Elevation Myocardial Infarction
- Open Access
- 10 January 2022
- Published by Wiley
An unusual case of recurrent ventricular tachycardia
Amiodarone is commonly used in acute care due to its effectiveness in several arrythmias and safety if structural heart disease is present or unknown. However, it can have a proarrhythmic effect. We presented a case of iatrogenic arrhythmic storm due to concomitant use of amiodarone plus tiapride resolved with isoproterenol.
- 10 January 2022
- Published by Wiley
Open AccessAn unusual case of recurrent ventricular tachycardia
Amiodarone is commonly used in acute care due to its effectiveness in several arrythmias and safety if structural heart disease is present or unknown. However, it can have a proarrhythmic effect. We presented a case of iatrogenic arrhythmic storm due to concomitant use of amiodarone plus tiapride resolved with isoproterenol.
- Open Access
- 1 January 2020
- Published by Walter de Gruyter GmbH in Journal of Critical Care Medicine
- Vol. 6 (1) , 41-51
Predictors of In-Hospital Mortality after Recovered Out-of-Hospital Cardiac Arrest in Patients with Proven Significant Coronary Artery Disease: A Retrospective Study
Introduction: Recovered Out-of-Hospital Cardiac Arrest (rOHCA) population is heterogenous. Few studies focused on outcomes in the rOHCA subgroup with proven significant coronary artery disease (SigCAD). We aimed to characterize this subgroup and study the determinants of in-hospital mortality. Methods: Retrospective study of consecutive rOHCA patients submitted to coronary angiography. Only patients with SigCAD were included. Results: 60 patients were studied, 85% were male, mean age was 62.6 ± 12.1 years. In-hospital mortality rate was 43.3%. Patients with diabetes and history of stroke were less likely to survive. Significant univariate predictors of in-hospital mortality were further analysed separately, according to whether they were present at hospital admission or developed during hospital evolution. At hospital admission, initial non-shockable rhythm, low-flow time>12min, pH4.75mmol/L were the most relevant predictors and therefore included in a score tested by Kaplan-Meyer. Patients who had 0/4 criteria had 100% chance of survival till hospital discharge, 1/4 had 77%, 2/4 had 50%, 3/4 had 25%. Patients with all 4 criteria had 0% survival. During in-hospital evolution, a pH2mmol/L at 24h, anoxic brain injury and persistent hemodynamic instability proved significant. Patients who had 0/4 of these in-hospital criteria had 100% chance of survival till hospital discharge, 1/4 had 94%, 2/4 had 47%, 3/4 had 25%. Patients with all 4 criteria had 0% survival. Contrarily, CAD severity and ventricular dysfunction didn’t significantly correlate to the outcome. Conclusion: Classic prehospital variables retain their value in predicting mortality in the specific group of OHCA with SigCAD. In-hospital evolution variables proved to add value in mortality prediction. Combining these simple variables in risk scores might help refining prognostic prediction in these patients’s subset.
- 1 January 2020
- Published by Walter de Gruyter GmbH in Journal of Critical Care Medicine
- Vol. 6 (1) , 41-51
Open AccessPredictors of In-Hospital Mortality after Recovered Out-of-Hospital Cardiac Arrest in Patients with Proven Significant Coronary Artery Disease: A Retrospective Study
Introduction: Recovered Out-of-Hospital Cardiac Arrest (rOHCA) population is heterogenous. Few studies focused on outcomes in the rOHCA subgroup with proven significant coronary artery disease (SigCAD). We aimed to characterize this subgroup and study the determinants of in-hospital mortality. Methods: Retrospective study of consecutive rOHCA patients submitted to coronary angiography. Only patients with SigCAD were included. Results: 60 patients were studied, 85% were male, mean age was 62.6 ± 12.1 years. In-hospital mortality rate was 43.3%. Patients with diabetes and history of stroke were less likely to survive. Significant univariate predictors of in-hospital mortality were further analysed separately, according to whether they were present at hospital admission or developed during hospital evolution. At hospital admission, initial non-shockable rhythm, low-flow time>12min, pH4.75mmol/L were the most relevant predictors and therefore included in a score tested by Kaplan-Meyer. Patients who had 0/4 criteria had 100% chance of survival till hospital discharge, 1/4 had 77%, 2/4 had 50%, 3/4 had 25%. Patients with all 4 criteria had 0% survival. During in-hospital evolution, a pH2mmol/L at 24h, anoxic brain injury and persistent hemodynamic instability proved significant. Patients who had 0/4 of these in-hospital criteria had 100% chance of survival till hospital discharge, 1/4 had 94%, 2/4 had 47%, 3/4 had 25%. Patients with all 4 criteria had 0% survival. Contrarily, CAD severity and ventricular dysfunction didn’t significantly correlate to the outcome. Conclusion: Classic prehospital variables retain their value in predicting mortality in the specific group of OHCA with SigCAD. In-hospital evolution variables proved to add value in mortality prediction. Combining these simple variables in risk scores might help refining prognostic prediction in these patients’s subset.
- 6 August 2016
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 12 (1) , 63-68
Predictors of hospital readmission 1 year after ischemic stroke
- 6 August 2016
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 12 (1) , 63-68
Predictors of hospital readmission 1 year after ischemic stroke
- 1 March 2016
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 25 (3) , 511-514
Wake-up Stroke and Stroke within the Therapeutic Window for Thrombolysis Have Similar Clinical Severity, Imaging Characteristics, and Outcome
- 1 March 2016
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 25 (3) , 511-514
Wake-up Stroke and Stroke within the Therapeutic Window for Thrombolysis Have Similar Clinical Severity, Imaging Characteristics, and Outcome
- 15 May 2010
- Published by Taylor & Francis
- p. 14-47
Coronary Artery Bifurcation Lesions